tradingkey.logo

tradingkey.logo
怜玢


Intelligent Bio Solutions Inc

INBS
りォッチリストに远加
4.010USD
-0.100-2.43%
終倀 05/15, 16:00ET15分遅れの株䟡
9.59M時䟡総額
損倱額盎近12ヶ月PER


詳现情報 Intelligent Bio Solutions Inc 䌁業名

Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.

Intelligent Bio Solutions Incの䌁業情報


䌁業コヌドINBS
䌚瀟名Intelligent Bio Solutions Inc
䞊堎日Dec 23, 2020
最高経営責任者「CEO」Simeonidis (Harry)
埓業員数16
蚌刞皮類Ordinary Share
決算期末Dec 23
本瀟所圚地135 W 41St St,
郜垂NEW YORK
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号10036
電話番号16467905756
りェブサむトhttps://ibs.inc/
䌁業コヌドINBS
䞊堎日Dec 23, 2020
最高経営責任者「CEO」Simeonidis (Harry)

Intelligent Bio Solutions Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
34.54K
+88.30%
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
5.01K
+99.88%
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
5.00K
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
5.00K
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
34.54K
+88.30%
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
5.01K
+99.88%
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
5.00K
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
5.00K
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--

収益内蚳

通貚: USD曎新時刻: Mon, Apr 6
通貚: USD曎新時刻: Mon, Apr 6
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
United Kingdom
846.88K
94.44%
Rest of world
40.73K
4.54%
Americas
7.63K
0.85%
Australia
1.54K
0.17%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Sun, May 10
曎新時刻: Sun, May 10
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Sakiris (Spiro Kevin)
1.65%
Simeonidis (Harry)
1.59%
Vanguard Capital Management, LLC
0.27%
Boyages (Steven Constantine)
0.23%
Hurd (Jonathan S)
0.23%
他の
96.04%
株䞻統蚈
株䞻統蚈
比率
Sakiris (Spiro Kevin)
1.65%
Simeonidis (Harry)
1.59%
Vanguard Capital Management, LLC
0.27%
Boyages (Steven Constantine)
0.23%
Hurd (Jonathan S)
0.23%
他の
96.04%
皮類
株䞻統蚈
比率
Individual Investor
4.16%
Investment Advisor
0.47%
Hedge Fund
0.06%
他の
95.31%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
29
1.95K
0.09%
-189.19K
2025Q4
30
129.36K
10.64%
-1.19K
2025Q3
31
799.23K
8.80%
-446.50K
2025Q2
34
836.82K
11.26%
+144.79K
2025Q1
36
981.28K
14.20%
+429.65K
2024Q4
38
214.35K
3.16%
-507.92K
2024Q3
38
390.00K
7.80%
-236.97K
2024Q2
42
449.42K
76.55%
-259.12K
2024Q1
46
732.30K
88.07%
+589.21K
2023Q4
40
172.56K
98.30%
+79.74K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Sakiris (Spiro Kevin)
35.89K
1.79%
+30.50K
+565.55%
Mar 18, 2026
Simeonidis (Harry)
34.54K
1.73%
+30.50K
+754.76%
Mar 18, 2026
Boyages (Steven Constantine)
5.03K
0.25%
+5.00K
+16129.03%
Mar 18, 2026
Hurd (Jonathan S)
5.01K
0.25%
+5.00K
+83333.33%
Mar 18, 2026
Fraser (Nicola Marion)
5.00K
0.25%
+5.00K
--
Mar 18, 2026
Isenberg (Jason)
5.00K
0.25%
+5.00K
--
Mar 18, 2026
Tower Research Capital LLC
1.26K
0.06%
+1.26K
--
Dec 31, 2025
UBS Financial Services, Inc.
4.05K
0.2%
+4.05K
--
Dec 31, 2025
詳现を芋る

関連ETF


銘柄名
比率
デヌタなし

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
Dec 12, 2025
Merger
10→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Feb 09, 2023
Merger
20→1
日付
配圓萜ち日
皮類
比率
Dec 12, 2025
Merger
10→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
KeyAI
î™